Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
α-NETA
60
CHF
CHF 60.00
In stock
AG-CR1-0151-M0055 mgCHF 60.00
AG-CR1-0151-M02525 mgCHF 240.00
Product Details | |
---|---|
Synonyms | 2-(α-Naphthoyl)ethyltrimethylammonium iodide |
Product Type | Chemical |
Properties | |
Formula |
C16H20INO |
MW | 369.2 |
CAS | 31059-54-8 |
Purity Chemicals | ≥97% (NMR) |
Appearance | White to off-white solid. |
Solubility | Soluble in methanol or DMSO (3mg/ml). Sparingly soluble in water. |
Identity | Determined by 1H-NMR. |
Other Product Data |
Handling Note: |
InChi Key | QZXMJYVXMZJOAO-UHFFFAOYSA-M |
Smiles | [I-].C[N+](C)(C)CCC(=O)C1=C2C=CC=CC2=CC=C1 |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Potent fluorescent inhibitor of choline acetyltransferase.
- CMKLR1 antagonist. Inhibits chemerin-stimulated β-arrestin2 association with CMKLR1, as well as chemerin-triggered CMKLR1+ cell migration.
- Aldehyde dehydrogenase 1 (ALDH1A1) antagonist.
Product References
- 2-(alpha-Naphthoyl)ethyltrimethylammonium iodide and its beta-isomer: new selective, stable and fluorescent inhibitors of choline acetyltransferase: B.V. Sastry, et al.; J. Pharmacol. Exp. Ther. 245, 72 (1988)
- Relationships between chemical structure and inhibition of choline acetyltransferase by 2-(alpha-naphthoyl)ethyl trimethylammonium and related compounds: B.V. Sastry, et al.; Pharmacol. Res. Commun. 20, 751 (1988)
- Regulation of the choline transport system in superfused microcarrier cultures of BeWo cells: B.M Eaton & S.R. Sooranna; Placenta 19, 663 (1998)
- Eosinophil-induced release of acetylcholine from differentiated cholinergic nerve cells: D.A. Sawatzky, et al.; Am. J. Physiol. Lung Cell Mol. Physiol. 285, L1296 (2003)
- A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease: K.L. Graham, et al.; PLoS One 9, e112925 (2014)